Corapace

Corapace: description, application and side effects

Corapace (international name - disopyramide) is a group 1A antiarrhythmic membrane-stabilizing agent produced by ICN Galenika in Yugoslavia. The dosage form of Corapace is capsules containing 150 mg of the active substance - disopyramide.

Corapace is used to treat ventricular arrhythmias and high-grade extrasystoles. However, the drug has a number of contraindications, such as hypersensitivity to disopyramide, cardiogenic shock, AV block II-III degree, long QT syndrome and sinus node weakness. The use of Corapace should also be avoided during pregnancy and breastfeeding.

In addition, Corapace has a number of side effects, including a proarrhythmogenic effect, hypotension, progression of heart failure, widening of the QRS complex, AV block of the first degree, hypoglycemia, blurred vision, increased intraocular pressure, xerostomia, atony of the intestine and bladder, dyspepsia, headache , dizziness and allergic reactions.

Although there is no data on the interaction of Corapace with other drugs, caution should be exercised when using Corapace simultaneously with other drugs.

In general, Corapace is an effective drug for the treatment of ventricular arrhythmias and high-grade extrasystoles, however, before using it, you must consult a specialist and become familiar with contraindications and possible side effects. Literature including the 2000 Drug Encyclopedia and the 1997/1998 Drug Register may also be helpful in learning about Corapace.